# Nanoscope Therapeutics Appoints Ophthalmology and Rare Disease Regulatory Leader Damon Daulerio as Executive Director of Regulatory Affairs

- Source: PR Newswire M&A
- Published: 2026-11-05T12:03:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/nanoscope-therapeutics-appoints-ophthalmology-and-rare-disease-regulatory-leader-damon-daulerio-as-executive-director-of-regulatory-affairs-302930126.html
- Canonical: https://groundlevelnews.com/story/nanoscope-therapeutics-appoints-ophthalmology-and-rare-disease-regulat-adb954/

Global regulatory affairs leader with 30 years in the pharmaceutical industry, including 28 years in regulatory affairs spanning development, registration, and lifecycle management Most recently led FDA interactions as Senior Director, Regulatory Affairs (Rare Diseases) at Insmed;...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._